Trials / Completed
CompletedNCT00892229
Buccal Versus Vaginal Misoprostol in Surgical Termination of the First Trimester Missed Abortion in Erbil
Buccal Versus Vaginal Misoprostol for Cervical Ripening Prior to Surgical Termination of the First Trimester Missed Abortion in Erbil
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Hawler Medical University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effectiveness of buccal misoprostol and comparing this with vaginal route of the same drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol (given buccally) | 400 microgram misoprostol given buccally three hours before dilation and curettage (PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms) |
| DRUG | Misoprostol (given vaginally) | 400 microgram misoprostol (MISOPROSTOL - PHARMACIA CORPORATION - Istanbul, serial number 022-00, a tablet contains 200 micrograms) |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-01-01
- Completion
- 2008-03-01
- First posted
- 2009-05-04
- Last updated
- 2009-05-04
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT00892229. Inclusion in this directory is not an endorsement.